Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)
20.40
+2.26 (12.46%)
May 2, 2025, 4:08 PM HKT
HKG:2190 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Net Income | - | -78.73 | -113.56 | -199.69 | -100.47 | Upgrade
|
Depreciation & Amortization | - | 35.88 | 26.27 | 13.38 | 9.64 | Upgrade
|
Loss (Gain) From Sale of Assets | - | 0.59 | 9.13 | -0.02 | -0.03 | Upgrade
|
Loss (Gain) From Sale of Investments | - | 8.53 | -4.78 | -13.93 | -1.62 | Upgrade
|
Stock-Based Compensation | - | 85.77 | 87.68 | 76.21 | 23.11 | Upgrade
|
Other Operating Activities | - | 13.63 | -23.52 | 5 | 1.27 | Upgrade
|
Change in Accounts Receivable | - | -0.17 | -0.57 | -0.33 | 0.88 | Upgrade
|
Change in Inventory | - | -47.3 | -61.97 | -28.28 | -19.04 | Upgrade
|
Change in Accounts Payable | - | 36.39 | 36.76 | 44.55 | 16 | Upgrade
|
Change in Unearned Revenue | - | - | - | - | -4.5 | Upgrade
|
Change in Other Net Operating Assets | - | 43.86 | -46.75 | -13.11 | -7.58 | Upgrade
|
Operating Cash Flow | - | 98.44 | -91.32 | -116.21 | -82.33 | Upgrade
|
Capital Expenditures | - | -190.92 | -134.74 | -78.11 | -45.14 | Upgrade
|
Sale of Property, Plant & Equipment | - | 0.39 | - | 0.11 | 0.04 | Upgrade
|
Sale (Purchase) of Intangibles | - | - | -10.55 | -11.49 | - | Upgrade
|
Investment in Securities | - | -24.39 | 50.24 | -1,239 | -204.08 | Upgrade
|
Other Investing Activities | - | 8.67 | - | - | - | Upgrade
|
Investing Cash Flow | - | -206.24 | -95.05 | -1,328 | -249.18 | Upgrade
|
Long-Term Debt Issued | - | 50 | - | 5 | 35.5 | Upgrade
|
Long-Term Debt Repaid | - | -6.41 | -4.89 | -39.2 | -25.67 | Upgrade
|
Net Debt Issued (Repaid) | - | 43.59 | -4.89 | -34.2 | 9.83 | Upgrade
|
Issuance of Common Stock | - | - | - | 2,968 | 336.38 | Upgrade
|
Repurchase of Common Stock | - | -53.8 | -24.64 | -9.15 | - | Upgrade
|
Other Financing Activities | - | -1.25 | -0.72 | -115.06 | -0.67 | Upgrade
|
Financing Cash Flow | - | -11.46 | -30.26 | 2,810 | 345.54 | Upgrade
|
Foreign Exchange Rate Adjustments | - | 0.54 | 3.57 | -6.46 | -0.6 | Upgrade
|
Net Cash Flow | - | -118.72 | -213.06 | 1,359 | 13.43 | Upgrade
|
Free Cash Flow | - | -92.48 | -226.06 | -194.32 | -127.47 | Upgrade
|
Free Cash Flow Margin | - | -17.52% | -67.66% | -109.22% | -461.34% | Upgrade
|
Free Cash Flow Per Share | - | -0.28 | -0.68 | -0.66 | -0.65 | Upgrade
|
Cash Interest Paid | - | 1.25 | 0.72 | 0.31 | 0.67 | Upgrade
|
Levered Free Cash Flow | - | -48.19 | -226.74 | -129.84 | -75.74 | Upgrade
|
Unlevered Free Cash Flow | - | -47.41 | -226.29 | -129.65 | -75.32 | Upgrade
|
Change in Net Working Capital | 58.84 | -113.84 | 55.26 | -6.7 | 2.1 | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.